Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Original Research



Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience

Tarik Demir, Murat Araz, Ezgi Coban, Altay Aliyev, Mesut Seker, Haci Mehmet Turk.

Abstract
Primary tumor location (PTL) is associated with very different outcomes in patients with metastatic colorectal cancer (mCRC). Clinical trials suggest that right side tumor location is an indicator of poor prognosis for patients with mCRC. The relationship between the primary tumor location and clinicopathological features such as; gender, family history, carcinoembryonic antigen (CEA) level, metastasectomy status, the presence of a mucinous component, RAS mutation status, and overall survival (OS) were evaluated. A total of 253 patients (203 left-sided, 50 right-sided) were included in the study. Median OS time for patients with metastatic right sided colon tumors were 19 (15.2-22.7) months, and OS for left sided colon tumors were 35 (29.5-40.4) months. The left-sided colon group’s OS time was significantly higher than the right-sided colon group (p

Key words: Metastatic colorectal cancer, primary tumor location, prognostic factor



Similar Articles

Disparities in Genetic Testing for Heritable Solid-Tumor Malignancies.
Dillon J, Ademuyiwa FO, Barrett M, Moss HA, Wignall E, Menendez C, Hughes KS, Plichta JK
Surgical oncology clinics of North America. 2022; 31(1): 109-126

MTA1, a metastasis‑associated protein, in endothelial cells is an essential molecule for angiogenesis.
Ishikawa M, Osaki M, Uno N, Ohira T, Kugoh H, Okada F
Molecular medicine reports. 2022; 25(1):

Financial Toxicity and Shared Decision Making in Oncology.
Greenup RA
Surgical oncology clinics of North America. 2022; 31(1): 1-7

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson's disease.
Goulding SR, Anantha J, Collins LM, Sullivan AM, O'Keeffe GW
Neural regeneration research. 2022; 17(1): 38-44

Epsin 3 potentiates the NF‑κB signaling pathway to regulate apoptosis in breast cancer.
Wu Q, Li Q, Zhu W, Zhang X, Li H
Molecular medicine reports. 2022; 25(1):


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.



ScopeMed Web Sites